Pneumonia in term neonates: laboratory studies and duration of antibiotic therapy

J Perinatol. 2003 Jul-Aug;23(5):372-7. doi: 10.1038/sj.jp.7210949.

Abstract

Objectives: To compare 2 days of antibiotic therapy (AT) to 4 days of AT in neonates with pneumonia and to assess the usefulness of neutrophil values (NV), C-reactive protein (CRP), and procalcitonin (PCT) in this population.

Design: The study population consisted of consecutive, eligible term neonates begun on AT for suspected pneumonia. Of 51 neonates, 26 qualified for randomization (14, 2-day group; 12, 4-day group). NV were obtained with the initial evaluation and 12 and 24 hours later. CRP and PCT were obtained 12 and 48 hours after the initial evaluation.

Results: None of the 12 neonates in the 4-day group developed recurrent respiratory symptoms. Three of the 14 neonates randomized to the 2-day group had recurrence of symptoms, resulting in study termination. NV, CRP, and PCT were similar in the 2- and 4-day groups. In the three neonates who developed respiratory symptoms, all absolute total neutrophil values and five out of nine absolute total immature neutrophil values were abnormal. However, all immature:total neutrophil values were normal, and CRP was strikingly elevated in only one neonate; only one of six PCT values was abnormal. In a secondary analysis of all 51 study neonates, CRP and PCT did not provide additional benefit over NV in differentiating neonates with pneumonia.

Conclusions: Four days of AT appears to be adequate for selected term neonates with pneumonia; however, 2 days of AT appears to be inadequate for this population. Relative to NV, CRP and PCT appear to have a limited role.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Ampicillin / administration & dosage
  • Anti-Bacterial Agents / administration & dosage*
  • Birth Weight
  • Clinical Laboratory Techniques
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Gentamicins / administration & dosage
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Injections, Intramuscular
  • Intensive Care Units, Neonatal
  • Male
  • Penicillins / administration & dosage
  • Pneumonia, Bacterial / diagnosis*
  • Pneumonia, Bacterial / drug therapy*
  • Probability
  • Prospective Studies
  • Reference Values
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Penicillins
  • Ampicillin